Search Results

These detailed tables are population tobacco and alcohol use totals and prevalence estimates from the 2012 National Survey on Drug Use and Health (NSDUH). Tobacco products include cigarettes, smokeless tobacco, cigars, and pipe tobacco. Alcohol use includes binge and heavy alcohol use. Results are provided for lifetime, past year, and...

These detailed tables present totals and prevalence estimates of risk and protective factors regarding substance use from the 2012 National Survey on Drug Use and Health (NSDUH). The factors include perceptions of 1) risk of substance use, 2) availability of substances, 3) parental disapproval of youth substance use, 4) peer...

These detailed tables present totals and prevalence estimates of substance use initiation from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants...

These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results...

This report presents current and prior methodological approaches for estimating the prevalence of serious mental illness (SMI) and any mental illness (AMI) among adults aged 18 or older using 2008 to 2012 National Survey on Drug Use and Health (NSDUH) data. Revised SMI and AMI estimates for 2012 are presented...

This report compares estimates of adult mental health from the 2009 National Survey on Drug Use and Health (NSDUH) with estimates of similar measures from 2001 to 2003 National Comorbidity Survey Replication (NCS-R), 2001 to 2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), 2007 Behavioral Risk Factor Surveillance...

This report compares estimates of youth substance use from the 2002 to 2008 National Survey on Drug Use and Health (NSDUH) with estimates of similar measures from Monitoring the Future (MTF) and the Youth Risk Behavior Survey (YRBS). Substances covered include cigarettes, alcohol, marijuana, cocaine, heroin, ecstasy, and inhalants. Results...

A Treatment Episode Data Set (TEDS) short report that analyzes the differences between treatment admissions involving persons who started using marijuana at age 17 or younger and those that initiated as adults. The report uses data from 2000-2010.

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) spotlight about the number of teen clients substance abuse treatment facilities accepted in the United States in 2012.

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits by status of follow-up care for drug-related suicide attempts involving antidepressants among adolescents aged 12 to 17 from 2008 to 2010.

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) spotlight about substance abuse treatment facilities that offered mental health screening in 2011.

This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...

This publication provides behavioral health statistics at the national and state levels from multiple data sources, including the National Survey on Drug Use and Health, the National Health Interview Survey, the Medical Expenditures Panel Survey, the National Association of State Mental Health Program Directors, as well as peer-reviewed journal articles.

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.